Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001213900-18-009317)

Filing Details

Accession Number:: 0001213900-18-009317
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-07-17 17:13:12
Reporting Period:: 2018-07-13

Accepted Time:: 2018-07-17 17:13:12
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1388320	Actinium Pharmaceuticals Inc.	ATNM	Pharmaceutical Preparations (2834)	880378336

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1566175	Sandesh Seth	C/O Actinium Pharmaceuticals, Inc. 275 Madison Avenue, 7Th Floor New York NY 10016	Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2018-07-17	10,000	$0.79	143,333	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Options to purchase common stock	Acquisiton	2018-07-13	1,000,000	$0.78	1,000,000	$0.78

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
1,000,000	2018-07-13	2028-07-13	No	4	A	Direct

Footnotes

Pursuant to the terms of the company's Amended and Restated 2013 Stock Plan, 2% of the options vest each month from the date of grant.